Results 1 to 2 of 2
Thread: Proscar with test,no hairloss?
-
01-19-2014, 06:38 AM #1
Proscar with test,no hairloss?
hello!i am on test prop and i have read that Proscar(finasteride) helps prevent hairloss from DHT conversion.is that the same in women as it is in men?if i take 1 mg proscar/day will it help prevent hairloss?
i also read that adding spironolactone in my shampoo blocks the DHT receptors sittuated on the scalp,resulting in less hairfall,is that true also?
-
01-21-2014, 10:59 PM #2
Amongst women, the more aggressive hairloss compounds are things like Winstrol & Primobolan. That said, it can also happen w/ any other injectables, but I'd say, anecdotally, less than winstrol & primo.
Generally we'll recommend to use Nizoral shampoo (1% or 2%) and that tends to be sufficient. If you want to go w/ more, the general thought is that Proscar can be used w/ no issues for women.
http://consumerreports.org/cro/2012/...-men/index.htm
http://www.ncbi.nlm.nih.gov/pubmed/17454167
Gynecol Endocrinol. 2007 Mar;23(3):142-5.
Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone.
Kohler C, Tschumi K, Bodmer C, Schneiter M, Birkhaeuser M.
Author information
Abstract
BACKGROUND:
In some women with acne or alopecia who have normal serum levels of free testosterone, no clinical improvement can be reached by the classical treatment with antiandrogens, isotretinoids or corticosteroids. Our hypothesis is that some of these women have an excessive activity of the enzyme 5alpha-reductase.
OBJECTIVE:
To evaluate the subjective benefit of the treatment with finasteride (5 mg/day) in women with normal serum levels of free testosterone suffering from acne or alopecia.
DESIGN:
This was a retrospective study evaluating a questionnaire filled out by 12 patients, six of whom had acne and six of whom had alopecia.
RESULTS:
Nine of the 12 patients benefited from the treatment, their symptoms decreased significantly and they felt better psychologically than before the administration of finasteride. The other three patients did not benefit at all from finasteride and reported no change in the extent of the acne/alopecia. Treatment was generally well tolerated, only a few adverse effects were noted.
CONCLUSIONS:
Nine of the 12 patients benefited from the treatment. This supports our hypothesis of an excessive activity of 5alpha-reductase enzyme in peripheral tissue in these patients. The fact that three of the patients did not realize any change in their symptom severity implies that there must also be other pathways in the genesis of acne and alopecia in women with normal levels of free testosterone. Further evaluation is needed to elucidate more precise indications for the administration of finasteride in women with acne and alopecia.
PMID: 17454167 [PubMed - indexed for MEDLINE]
Bookmarks